您的购物车当前为空
Most local anesthetics act by abolishing voltage gated sodium channel currents indiscriminately in all populations of neurons. Selective analgesia through TRPV1-mediated entry of a cationic lidocaine derivative, QX314, was recently reported. CAY10568 is a physically smaller, less hydrophobic version of QX314 designed to be even more permeable to TRPV1 ion channel when activated by agonists such as capsaicin and N-oleoyl dopamine. CAY10568 when given in combination with suitable TRPV1 agonists should produce selective blockade of the pain response while leaving motor, touch, and proprioception intact.
Most local anesthetics act by abolishing voltage gated sodium channel currents indiscriminately in all populations of neurons. Selective analgesia through TRPV1-mediated entry of a cationic lidocaine derivative, QX314, was recently reported. CAY10568 is a physically smaller, less hydrophobic version of QX314 designed to be even more permeable to TRPV1 ion channel when activated by agonists such as capsaicin and N-oleoyl dopamine. CAY10568 when given in combination with suitable TRPV1 agonists should produce selective blockade of the pain response while leaving motor, touch, and proprioception intact.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥ 938 | 35日内发货 | |
| 25 mg | ¥ 2,170 | 35日内发货 | |
| 50 mg | ¥ 3,970 | 35日内发货 | |
| 100 mg | ¥ 7,170 | 35日内发货 |
| 产品描述 | Most local anesthetics act by abolishing voltage gated sodium channel currents indiscriminately in all populations of neurons. Selective analgesia through TRPV1-mediated entry of a cationic lidocaine derivative, QX314, was recently reported. CAY10568 is a physically smaller, less hydrophobic version of QX314 designed to be even more permeable to TRPV1 ion channel when activated by agonists such as capsaicin and N-oleoyl dopamine. CAY10568 when given in combination with suitable TRPV1 agonists should produce selective blockade of the pain response while leaving motor, touch, and proprioception intact. |
| 分子量 | 320.174 |
| 分子式 | C11H17IN2O |
| CAS No. | 22913-17-3 |
| Smiles | [I-].C[N+](C)(C)CC(=O)Nc1ccccc1 |
| 存储 | |||||||||||||||||||||||||||||||
| 溶解度信息 | PBS (pH 7.2): 0.5 mg/mL (1.56 mM), Sonication is recommended. DMF: 5 mg/mL (15.62 mM), Sonication is recommended. DMSO: 3 mg/mL (9.37 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
PBS (pH 7.2)/DMSO/DMF
DMSO/DMF
DMF
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | |||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多